Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX
Step-by-step guide for reviewing an electrocardiogram (ECG) in patients taking antipsychotic medication:
- Obtain baseline ECG before starting antipsychotic treatment, especially if the drug's Summary of Product Characteristics (SPC) specifies it, or if the patient has cardiovascular risk factors such as hypertension, personal or family history of cardiovascular disease, or is inpatient NICE CG178,NICE CG155.
- Perform regular ECG monitoring for antipsychotics known to significantly prolong the QT interval, particularly haloperidol, pimozide, and sertindole, with annual ECGs being mandatory for these drugs NICE CKS,NICE CKS.
- Monitor ECG after dose changes or if new medications that may prolong QT interval are added NICE CKS.
- Measure and interpret the QT interval: a QT corrected interval (QTc) greater than 450 milliseconds warrants concern, and a QTc over 500 milliseconds requires urgent specialist psychiatric advice NICE CKS,NICE CKS.
- Evaluate for ECG features that increase arrhythmia risk, such as prolonged QT interval and other conduction abnormalities; seek specialist advice if uncertain NICE CKS.
- Record and send ECG findings to the patient's care coordinator or psychiatrist as part of the annual physical health review NICE CKS.
Additional clinical information to assist interpretation:
- Note drug-specific risks: haloperidol, pimozide, and sertindole carry highest QT prolongation risk; other antipsychotics have variable effects on ECG NICE CKS,NICE CKS.
- Consider patient-specific factors including electrolyte imbalances, concomitant medications that prolong QT, and smoking status affecting drug metabolism and cardiac risk NICE CKS,NICE CKS.
- Recognize that clozapine may cause ECG changes such as ST segment depression and T wave inversion, which may normalize after stopping, but may indicate myocarditis; signs of myocarditis include persistent tachycardia, palpitations, arrhythmias, chest pain, and symptoms mimicking myocardial infarction—these warrant further cardiac evaluation SmPC Clozaril,SmPC Clozaril,SmPC Zaponex,SmPC Zaponex.
- Be aware of symptoms potentially related to cardiac effects of antipsychotics, including palpitations, unexplained fatigue, dyspnoea, or syncope that may suggest arrhythmia or myocarditis SmPC Clozaril,SmPC Clozaril,SmPC Zaponex,SmPC Zaponex,NHS Long QT,NHS Heart rhythm.
- Gather history of substance use (alcohol, tobacco, other drugs) as these can affect cardiac risk and drug metabolism NICE CKS,NICE CG185.
- Obtain and consider other baseline and ongoing physical health measures such as electrolytes, renal function, and cardiovascular risk factors to contextualize ECG findings NICE CKS,NICE CKS.
Key References
- NICE CKS: Schizophrenia and psychosis
- NICE CKS: Psychosis and schizophrenia
- NICE CKS: Palpitations
- NICE CG178: Psychosis and schizophrenia in adults: prevention and management
- SmPC: Clozaril and Clozapine 25 mg Tablets
- SmPC: Clozaril and Clozapine 100 mg Tablets
- SmPC: Zaponex Orodispersible tablets
- SmPC: Zaponex 25 and 100 mg Tablets
- NICE CG185: Bipolar disorder: assessment and management
- NICE CG155: Psychosis and schizophrenia in children and young people: recognition and management
- NHS: Long QT syndrome
- NHS: Heart rhythm problems (arrhythmia)